Rhode Island IDeA Network of Biomedical Research Excellence

Information

  • Research Project
  • 10192735
  • ApplicationId
    10192735
  • Core Project Number
    P20GM103430
  • Full Project Number
    5P20GM103430-21
  • Serial Number
    103430
  • FOA Number
    PAR-18-262
  • Sub Project Id
  • Project Start Date
    9/30/2001 - 23 years ago
  • Project End Date
    4/30/2024 - 6 months ago
  • Program Officer Name
    ZHOU, YANG
  • Budget Start Date
    5/1/2021 - 3 years ago
  • Budget End Date
    4/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    21
  • Suffix
  • Award Notice Date
    5/19/2021 - 3 years ago

Rhode Island IDeA Network of Biomedical Research Excellence

PROJECT SUMMARY The overarching goal of Rhode Island-IDeA Network of Biomedical Research Excellence (RI-INBRE) is to improve institutional capacity for biomedical research excellence and to expand student experiential training opportunities in the State of Rhode Island. We will accomplish this goal by growing statewide institutional research capacity, supporting early career research faculty development, and by providing structured and mentored research training experiences for undergraduate and graduate students and postdoctoral fellows. RI- INBRE is comprised of two research-intensive institutions, the University of Rhode Island and Brown University, five primarily undergraduate institutions (PUIs)(Bryant University, Providence College, Rhode Island College, Roger Williams University, and Salve Regina University), and one community college, the Community College of Rhode Island. The University of Rhode Island (URI) is the lead institution of RI-INBRE and serves as the major network administrative and assessment hub. RI-INBRE will be composed of five major core components: the Administrative Core, the Bioinformatics Core, the Centralized Research Core Facility (CRCF) Core, the Training Core, and the Developmental Research Project Program (DRPP) Core. Since its inception in 2001, RI-INBRE has had a transformative impact on the biomedical research environment throughout Rhode Island and, in particular, at several of the network PUIs. We have accumulated a wealth of experience on how to develop and enhance a biomedical research environment through targeted investment and structured mentoring. The implementation of a successful research capacity building program requires sustained and long-term strategies. During the renewal period, we will build upon our successes to date and implement several new innovative strategies to expand the impact of the program and to develop a broadly inclusive, productive, and sustainable culture of biomedical research excellence in Rhode Island. The Ocean State is on the cusp of becoming a major player in biomedical research. Continued funding of RI-INBRE is essential to maintain a dynamic and well-trained biomedical workforce, to continue to promote biomedical research sea-changes at the network PUIs, and to promote investment and entrepreneurship in the biomedical sciences in Rhode Island.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    P20
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
    3204250
  • Indirect Cost Amount
    642000
  • Total Cost
    3846250
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
    SCHOOLS OF PHARMACY
  • Funding ICs
    NIGMS:3846250\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZGM1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF RHODE ISLAND
  • Organization Department
    PHARMACOLOGY
  • Organization DUNS
    144017188
  • Organization City
    KINGSTON
  • Organization State
    RI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    028810811
  • Organization District
    UNITED STATES